Skip to main content

Table 1 Reactions to vaccine components in studies with more than 25 participants

From: Vaccination in children with allergy to non active vaccine components

Vaccine component

Studies

Partecipants, N

Allergic reactions N (%)

Egg

Measles-mumps-rubella

  
 

  Goodyear-Smith et al. 2005 [9]

73

0 (0%)

 

  Erlewyn-LajeunesseM et al. 2008 [10]

100.000

42 (0.04%)

 

  Govindaraj P et al. 2009 [11]

45

0 (0%)

 

  Cronin J et al. 2012 [12]

310

6 (1.9%)

 

  Andersen DV et al. 2013 [13]

32

0 (0%)

 

Total

100.460

48 (0.04%)

 

Influenza

  
 

  Cerecedo C et al. 2007 [27]

26

0 (0%)

 

  Esposito S et al. 2008 [28]

44

3 (6.8%)

 

  Chung E et al. 2010 [29]

171

29 (16.9%)

 

  Gagnon R et al. 2010 [24]

830

9 (1.08%)

 

  Greenhawt MJ et al. 2010 [30]

105

0 (0%)

 

  Pien GC et al. 2010 [31]

62

0 (0%)

 

  Webb et al. 2011 [32]

152

2 (1.3%)

 

  Erlewyn-Lajeunesse M et al. 2011 [21]

3640

88(2.41%)

 

  Howe et al. 2011 [25]

135

0 (0%)

 

  Owens et al. 2011 [33]

64

4 (6.25%)

 

  Shuler JE et al. 2011 [34]

62

4 (6.4%)

 

  Fung et al. 2012 [35]

56

2 (3.5%)

 

  Greenhawt MJ et al. 2012 [26]

105

0 (0%)

 

  Wainwaring Upton JE et al. 2012 [36]

77

0 (0%)

 

  Des Roches et al. 2012 [23]

367

13 (3.54%)

 

  Forsdhal BA et al. 2012 [37]

80

3 (3.75%)

 

Total

5982

157 (2.62%)

Yeasts

  DiMiceli L et al. 2006 [45]

107

15 (14%)

Dextran

  Zanoni G et al. 2008 [62]

100.000

19 (0.01%)

Thimerosal

  Wattanakrai P et al. 2007 [72]

46

0 (0%)